Novo Nordisk + OpenAI 2026: How AI Is Now Designing the Next Diabetes and Obesity Drug
Novo Nordisk and OpenAI have partnered to use AI across the entire drug pipeline — from discovery to manufacturing. Here's what this means for medicine in 2026.
Read article